TOPIC

Serum Institute of India

News Reports

As Covid-19 vaccine precaution doses become available at private hospitals, Covishield and Covaxin prices cut to Rs 225

OpIndia Staff -
Serum Institute of India and Bharat Biotech reduce the price of Covishield and Covaxin vaccines to ₹225 per dose
News Reports

Serum Institute’s COVID-19 vaccine Covovax gets WHO approval for emergency use

OpIndia Staff -
Covovax, a vaccine developed by SII and US-based Novovax, became the 9th Covid-19 vaccine to be approved by the WHO
News Reports

On PM Modi’s birthday, India achieves record vaccination numbers, 2.5 crore doses in a single day

OpIndia Staff -
India shattered its own vaccination record on PM Modi’s 71st birthday, jabbing more than 2 crore vaccine doses in a single day
News Reports

Had to ‘fall at the feet’ of bureaucrats to get permissions: Serum Institute chairman Cyrus Poonawalla says no ‘maska polish’ required under PM Modi

OpIndia Staff -
Serum Institute chairman Cyrus Poonawalla recalls the governmental and bureaucratic hurdles he faced during the UPA regime
News Reports

Serum Institute of India to commence production of Russia’s Sputnik V vaccine from September: Details

OpIndia Staff -
The Serum Institute of India has already received cell and vector samples from Russia's Gamaleya Centre and the cultivation process has begun
News Reports

Covishield excluded from EU’s Green Pass: Adar Poonawalla says talking to European regulators and countries for clearance

OpIndia Staff -
Covishield vaccine is manufactured by the Serum Institute of India and developed by Oxford-AstraZeneca. AstraZeneca's EU-made vaccine Vaxzervria is included in the Green Pass.
News Reports

Serum Institute of India all set to manufacture Novavax’s COVID-19 vaccine Covovax, trial data demonstrates 90.4 overall efficacy

OpIndia Staff -
Adar Poonawalla, the CEO of SII, plans to launch Novavax's Covovax in India by September contingent upon the regulatory approvals
World

France President Emmanuel Macron slams Joe Biden administration for blocking vaccine raw material export to India

OpIndia Staff -
French President Emmanuel Macron took potshots at the Joe Biden administration for blocking export of Covod-19 raw materials.
News Reports

Not just indemnity, Pfizer wants disputes over vaccine supply under jurisdiction of US courts only, Indian govt in dilemma

OpIndia Staff -
The indemnity clause protects the company (in this case Pfizer) from any financial liability in case of legal disputes.
News Reports

How the Congress government backstabbed the Serum Institute of India during the swine flu epidemic

Dibakar Dutta -
Forced by circumstances, the Serum Institute of India had moved the Delhi High Court in June 2012 under section 9 of the Arbitration Act.
123...6Page 2 of 6

Latest News

Recently Popular